InvestorsHub Logo
icon url

Couch

01/10/14 9:48 PM

#83709 RE: Pharma Sleuth #83707

First Elite wasn't good enough to buy hold and accumulate in the .06 cent range for the first nine months of 2013, then Elite didn't have enough money to begin even a 505b2 trial, now Nasrat Hakim doesn't have enough or possibly any regulatory affairs experience. What next Nasrat lent the company $1 Million dollars with money he stole from the safe at Actavis before he retired???
icon url

dr_lowenstein

01/10/14 11:36 PM

#83737 RE: Pharma Sleuth #83707

What misinformation is that lol lol